Panel Discussion
Mohamed Alosh, FDA  *Alex Dmitrienko, Quintiles  Mohammad F Huque, FDA  David Li, Pfizer, Inc.  Lei Shen, Eli Lilly and Company  Richard Simon, National Cancer Institute 

Keywords: Subgroup

Panel Discussion.